MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03487nam a22005417a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
191010s20212021 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
0190-9622 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1016/j.jaad.2019.08.031 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
S0190-9622(19)32578-2 [pii] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
31437544 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Vulvovaginal Manifestations in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Prevention and Treatment. |
| 251 ## - Source |
|---|
| Source |
Journal of the American Academy of Dermatology. 85(2):523-528, 2021 Aug. |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
J Am Acad Dermatol. 85(2):523-528, 2021 Aug. |
| 252 ## - Abbreviated Source |
|---|
| Former abbreviated source |
J Am Acad Dermatol. 2019 Aug 19 |
| 253 ## - Journal Name |
|---|
| Journal name |
Journal of the American Academy of Dermatology |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2021 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2021 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
aheadofprint |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
ppublish |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2019-10-10 |
| 268 ## - Previous citation |
|---|
| -- |
Journal of the American Academy of Dermatology. 2019 Aug 19 |
| 269 ## - Original dates |
|---|
| Original fiscal year |
FY2020 |
| 501 ## - WITH NOTE |
|---|
| Local holdings |
Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - 2006 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
The prevalence of acute vulvovaginal involvement in toxic epidermal necrolysis may be as high as 70%; up to 28% of females will also develop chronic vulvovaginal sequelae. There is little consensus regarding prevention and treatment of the gynecological sequelae of both Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN). We review acute and chronic sequelae including erosions, scar formation, chronic skin changes, urethral complications, adenosis and malignant transformation, vulvodynia and dyspareunia. We provide comprehensive recommendations on acute and long-term vulvovaginal care in adult and pediatric SJS/TEN patients. Acutely, vulvovaginal treatment should include ultrapotent topical steroid, followed by a non-irritating barrier cream applied to vulvar and perineal lesions. A steroid should be used intravaginally along with vaginal dilation in all adults with vaginal involvement, but should be avoided in pre-pubertal adolescents. Menstrual suppression should be considered in all reproductive age patients until vulvovaginal lesions have healed. Finally, referrals to pelvic floor physical therapy and surgical subspecialties should be offered on a case-by-case basis. This guide summarizes the current available literature, combined with expert opinion of both dermatologists and gynecologists who treat a high volume of SJS/TEN patients. Copyright (c) 2019. Published by Elsevier Inc. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Stevens-Johnson Syndrome/co [Complications] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Vaginal Diseases/et [Etiology] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Vaginal Diseases/th [Therapy] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Vulvar Diseases/et [Etiology] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Vulvar Diseases/th [Therapy] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Female |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Humans |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Practice Guidelines as Topic |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Stevens-Johnson Syndrome/di [Diagnosis] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaginal Diseases/pc [Prevention & Control] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vulvar Diseases/pc [Prevention & Control] |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Washington Hospital Center |
| 656 ## - INDEX TERM--OCCUPATION |
|---|
| Department |
Dermatology |
| 656 ## - INDEX TERM--OCCUPATION |
|---|
| Department |
Obstetrics and Gynecology/Urogynecology |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Bradley, Sarah |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Cardis, Michael A |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Pasieka, Helena B |
| 790 ## - Authors |
|---|
| All authors |
Bradley SE, Cardis MA, Mauskar MM, Mitchell CM, O'Brien KF, Pasieka HB |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.1016/j.jaad.2019.08.031">https://dx.doi.org/10.1016/j.jaad.2019.08.031</a> |
| Public note |
https://dx.doi.org/10.1016/j.jaad.2019.08.031 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
